117 related articles for article (PubMed ID: 12574226)
1. Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas.
Mune T; Morita H; Suzuki T; Takahashi Y; Isomura Y; Tanahashi T; Daido H; Yamakita N; Deguchi T; Sasano H; White PC; Yasuda K
J Clin Endocrinol Metab; 2003 Feb; 88(2):864-70. PubMed ID: 12574226
[TBL] [Abstract][Full Text] [Related]
2. Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity.
Mazzocchi G; Aragona F; Malendowicz LK; Gottardo L; Nussdorfer GG
J Investig Med; 2001 Mar; 49(2):191-4. PubMed ID: 11288760
[TBL] [Abstract][Full Text] [Related]
3. Enzyme histo-cytochemical studies in human adrenocortical adenomas. [II] Cushing's syndrome.
Murakoshi M; Osamura Y; Watanabe K; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1983 Jul; 8(3):293-300. PubMed ID: 6322390
[TBL] [Abstract][Full Text] [Related]
4. Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis.
Teshima T; Matsumoto H; Okusa T; Nakamura Y; Koyama H
PLoS One; 2015; 10(8):e0135516. PubMed ID: 26262685
[TBL] [Abstract][Full Text] [Related]
5. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
[TBL] [Abstract][Full Text] [Related]
6. Human adrenal cortex and aldosterone secreting adenomas express both 11beta-hydroxysteroid dehydrogenase type 1 and type 2 genes.
Albertin G; Tortorella C; Malendowicz LK; Aragona F; Neri G; Nussdorfer GG
Int J Mol Med; 2002 May; 9(5):495-8. PubMed ID: 11956655
[TBL] [Abstract][Full Text] [Related]
7. Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors.
Korbonits M; Bujalska I; Shimojo M; Nobes J; Jordan S; Grossman AB; Stewart PM
J Clin Endocrinol Metab; 2001 Jun; 86(6):2728-33. PubMed ID: 11397878
[TBL] [Abstract][Full Text] [Related]
8. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Mune T; Murase H; Yamakita N; Fukuda T; Murayama M; Miura A; Suwa T; Hanafusa J; Daido H; Morita H; Yasuda K
J Clin Endocrinol Metab; 2002 Dec; 87(12):5706-13. PubMed ID: 12466375
[TBL] [Abstract][Full Text] [Related]
9. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
[TBL] [Abstract][Full Text] [Related]
10. High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome associated with high secretion of adrenal androgens.
Sakai Y; Yanase T; Takayanagi R; Nakao R; Nishi Y; Haji M; Nawata H
J Clin Endocrinol Metab; 1993 May; 76(5):1286-90. PubMed ID: 8496319
[TBL] [Abstract][Full Text] [Related]
11. Markedly increased expression of cytochrome P-450 17 alpha-hydroxylase (P-450c17) mRNA in adrenocortical adenomas from patients with Cushing's syndrome.
Ogo A; Haji M; Ohashi M; Nawata H
Mol Cell Endocrinol; 1991 Sep; 80(1-3):83-9. PubMed ID: 1835446
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas.
Ilvesmäki V; Kahri AI; Miettinen PJ; Voutilainen R
J Clin Endocrinol Metab; 1993 Sep; 77(3):852-8. PubMed ID: 8370710
[TBL] [Abstract][Full Text] [Related]
13. In-vitro evidence for the regulation of 17,20-lyase activity by cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome.
Sakai Y; Yanase T; Hara T; Takayanagi R; Haji M; Nawata H
Clin Endocrinol (Oxf); 1994 Feb; 40(2):205-9. PubMed ID: 8137519
[TBL] [Abstract][Full Text] [Related]
14. A case of cortisol producing adrenal adenoma without phenotype of Cushing's syndrome due to impaired 11beta-hydroxysteroid dehydrogenase 1 activity.
Arai H; Kobayashi N; Nakatsuru Y; Masuzaki H; Nambu T; Takaya K; Yamanaka Y; Kondo E; Yamada G; Fujii T; Miura M; Komatsu Y; Kanamoto N; Ariyasu H; Moriyama K; Yasoda A; Nakao K
Endocr J; 2008 Aug; 55(4):709-15. PubMed ID: 18493111
[TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of glutathione-peroxidase (GSH-PO) in human adrenal gland--studies on adrenocortical adenomas associated with primary aldosteronism and Cushing's syndrome.
Murakoshi M; Osamura RY; Yoshimura S; Watanabe K
Tokai J Exp Clin Med; 1995 Jul; 20(2):89-97. PubMed ID: 8797265
[TBL] [Abstract][Full Text] [Related]
16. Role of local 11beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) expression in determining the phenotype of adrenal adenomas.
Mune T; Morita H; Suzuki T; Takahashi Y; Isomura Y; Tanahashi T; Daido H; Yamakita N; Deguchi T; Sasano H; Yasuda K; White PC
Endocr Res; 2002 Nov; 28(4):751-2. PubMed ID: 12530692
[No Abstract] [Full Text] [Related]
17. Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland.
Sasano H; Sato F; Shizawa S; Nagura H; Coughtrie MW
Mod Pathol; 1995 Dec; 8(9):891-6. PubMed ID: 8751327
[TBL] [Abstract][Full Text] [Related]
18. Does central obesity reflect "Cushing's disease of the omentum"?
Bujalska IJ; Kumar S; Stewart PM
Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
[TBL] [Abstract][Full Text] [Related]
19. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors.
Lefrançois-Martinez AM; Bertherat J; Val P; Tournaire C; Gallo-Payet N; Hyndman D; Veyssière G; Bertagna X; Jean C; Martinez A
J Clin Endocrinol Metab; 2004 Jun; 89(6):3010-9. PubMed ID: 15181092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
